
Short Title: NRG-BR009/OFSET
Enrollment Status: Recruiting
NCT #: NCT05879926
Specialty Area: Oncology
Condition Studied: Early Stage Breast Cancer
Age Groups: Adult; Older Adult
Phase: III
To find out if adding chemotherapy to ovarian function suppression and endocrine therapy helps prevent breast cancer from coming back in premenopausal patients with ER+/HER2− tumors and a low to intermediate Oncotype Recurrence Score.

Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT05879926
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.